Levosulpiride (75mg), Esomeprazole (40mg)
A sustained-release capsule combining a prokinetic agent and a proton pump inhibitor, used for the effective management of gastroesophageal reflux disease (GERD) and functional dyspepsia. It addresses both acid-related symptoms and associated nausea, bloating, and delayed gastric emptying. The sustained-release formulation ensures prolonged action for better symptom control throughout the day. Swallow the capsule whole before meals. Common side effects include headache, dry mouth, stomach pain, and potentially increased prolactin levels. Do not crush or chew the capsule.
GERD, Dyspepsia
Headache, Dry mouth, Stomach pain, Increased prolactin levels
Take this medicine in the exact dose and duration as prescribed by your doctor. It should be taken before food.
Unsafe
Unsafe
Unsafe
Unsafe
Caution
Caution
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
In case of any issue, contact us
E-mail address: support@zeptonow.com
Geddit Convenience Private Limited
Geddit Convenience Private Limited, Unit 803, Lodha Supremus, Saki Vihar Road, Opp MTNL, Office, Powai, Mumbai, Maharashtra, India,400072 For Support ReachOut : support+geddit@zeptonow.com
KA-B61-283317, KA-B61-283318
90, Delhi - Jaipur Road, Sector 32, Gurugram, Haryana 122001
India
Sun Pharma Laboratories Limited
30 months
September 2026